Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Oxford BioTherapeutics hires Head of Clinical Development
Oxford BioTherapeutics hires Head of Clinical Development
Dr Eugen Leo takes the position
Mitie Group appoints manufacturing specialist for its Environmental+ business
Mitie Group appoints manufacturing specialist for its Environmental+ business
Gareth Smallman becomes Director of Manufacturing, Industrial and Specialist Services
Biotec Services appoints Martin Lamb as Commercial Director
Biotec Services appoints Martin Lamb as Commercial Director
He has more than 20 years of industry experience
Winners of the Chemical Industry Awards 2014 announced
Winners of the Chemical Industry Awards 2014 announced
Novartis and GSK are honoured
Aesica recruits Business Development Manager
Aesica recruits Business Development Manager
Nadine Reuter will help drive sales in Germany, Austria and Switzerland
Intertek appoints Laboratory Director of Immunochemistry Centre of Excellence
Intertek appoints Laboratory Director of Immunochemistry Centre of Excellence
Dr Sarah Harris will lead the team in San Diego
C4X Discovery appoints Piers Morgan as Chief Executive
C4X Discovery appoints Piers Morgan as Chief Executive
Succeeds Sam Williams who returns to Non-Executive Director role
Solstice Biologics expands management team following achievement of technology milestones
Solstice Biologics expands management team following achievement of technology milestones
Appoints Lou Tartaglia as President and CEO, while John Borgeson joins as CFO
Robbie Stewart and Jen Doody join PCI UK team
Robbie Stewart and Jen Doody join PCI UK team
New appointments in Business Development and Human Resource Management
Oxford BioTherapeutics appoints Chief Scientific Officer
Oxford BioTherapeutics appoints Chief Scientific Officer
Dr Keith Wilson joins the company from AbbVie
ViroCyt strengthens management team
ViroCyt strengthens management team
Cellular and molecular immunologist joins the company as Chief Technology Officer
Spinifex Pharmaceuticals appoints neuroscience expert as Chief Medical Officer
Spinifex Pharmaceuticals appoints neuroscience expert as Chief Medical Officer
Ronald Marcus joins the Australian-US biotechnology company
Biovision announces the winners of the Catalyzer and Investor Conference awards
Biovision announces the winners of the Catalyzer and Investor Conference awards
This year’s focus was on finance and innovation
Biotec Services CEO joins Welsh government advisory panel
Biotec Services CEO joins Welsh government advisory panel
Aims to maximise the position of Wales in the global life sciences industry
Simon Angeldorff stays as CEO at Envirotainer
Simon Angeldorff stays as CEO at Envirotainer
Following a successful six months as interim CEO at the company
Martin Auster joins Ascendis Pharma as Chief Business Officer
Martin Auster joins Ascendis Pharma as Chief Business Officer
The company uses its TransCon technology to create drugs that address unmet medical needs
Previous
1
…
127
128
129
130
(current)
131
132
133
…
216
Next
Trending Articles
New Managing Director for Shimadzu Europa
Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
BioDuro appoints Greg Makara to lead discovery chemistry
BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
EyeC expands OEM growth with new business development manager
Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
Three new commercial appointments for Symbiosis
Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
Lonza nominates Pearl Huang to board
Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation